Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/23andmes-ceo-files-plan-to-take-company-private/
https://www.globenewswire.com/news-release/2024/04/18/2865332/0/en/23andMe-announces-CEO-s-intention-to-pursue-a-potential-take-private.html
https://www.globenewswire.com/news-release/2024/04/05/2858732/0/en/23andMe-to-Present-Data-on-Two-Clinical-Stage-Immuno-Oncology-Programs-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com/news-release/2024/03/20/2849267/0/en/23andMe-Initiates-Phase-1-Clinical-Trial-for-its-Dual-Mechanism-Antibody-23ME-01473-Targeting-ULBP6.html
https://www.globenewswire.com/news-release/2024/03/19/2848499/0/en/23andMe-Launches-New-Feature-Connecting-Customers-to-Historical-Individuals-from-Hundreds-and-Even-Thousands-of-Years-Ago.html
https://www.globenewswire.com//news-release/2024/03/06/2841292/0/en/23andMe-Launches-New-Genetic-Reports-on-Common-Forms-of-Cancer.html
https://www.globenewswire.com//news-release/2024/03/05/2840938/0/en/23andMe-Announces-Three-Presentations-from-Clinical-Stage-Immuno-Oncology-Programs-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2024/02/07/2825537/0/en/23andMe-Reports-Third-Quarter-Fiscal-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/01/31/2820995/0/en/23andMe-Announces-FDA-Clearance-of-IND-Application-for-its-Dual-Mechanism-Antibody-23ME-01473-Targeting-ULBP6.html
https://www.globenewswire.com/news-release/2024/01/31/2820684/0/en/23andMe-Launches-Month-Long-Initiative-to-Amplify-ARRAY-s-Seat16-Program-for-Acclaimed-Film-ORIGIN-by-Ava-DuVernay.html